Patents by Inventor Jeffrey Dodge

Jeffrey Dodge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Selective estrogen receptor modulators
    Publication number: 20070111988
    Abstract: The present invention relates to a selective estrogen receptor modulators of formula I (I); or a pharmaceutical acid addition salt thereof; and of formula II (II); or a pharmaceutical salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
    Type: Application
    Filed: January 18, 2005
    Publication date: May 17, 2007
    Applicant: ELI LILLY AND COMPANY
    Inventors: Robert Dally, Jeffrey Dodge, Conrad Hummel, Scott Jones, Timothy Shepherd, Owen Wallace, Wayne Weber
  • Selective estrogen receptor modulators
    Publication number: 20070066595
    Abstract: The present invention relates to a selective estrogen receptor modulator of formula I: or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and uterine leiomyoma.
    Type: Application
    Filed: January 18, 2005
    Publication date: March 22, 2007
    Inventors: Jeffrey Dodge, Scott Frank, Conrad Hummel
  • Pentalfluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators
    Publication number: 20070054956
    Abstract: The present invention provides a compound of the formula (I) wherein R is —H, or —C1-C4 alkyl; R1 is —H, —OH, —O(C1-C4 alkyl), —SO2(C1-C4 alkyl), or halo; X is —O—, —CH2—, or —C(O)—; X1 is —O— or —NR2—; R2 is —H or —CH3; Y is —S—, —CH2CH2—, or —HC?CH—; m is 0, 1, 2, or 3; and n is 0 or 1; or a pharmaceutically acceptable salt thereof; pharmaceutical compositions thereof; and methods for inhibiting a disease associated with an aberrant physiological response to endogenous estrogen.
    Type: Application
    Filed: May 27, 2004
    Publication date: March 8, 2007
    Inventors: Jeffrey Dodge, Norman Hughes
  • Selective estrogen receptor modulators containing a phenylsulfonyl group
    Publication number: 20060183736
    Abstract: The present invention relates to a selective estrogen receptor modulator of formula I or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
    Type: Application
    Filed: July 16, 2003
    Publication date: August 17, 2006
    Inventors: Robert Dally, Jeffrey Dodge, Scott Frank, Scott Jones, Timothy Shepherd, Owen Wallace, Kin Fong, Conrad Hummel, George Lewis
  • Growth hormone secretagogues
    Publication number: 20050143318
    Abstract: What is disclosed are growth hormone secretagogues, and their uses, of formula (I) wherein R1 is C6H5CH2OCH2—, C6H5(CH2)3— or indol-3-ylmethyl; Y is pyrrolidin-1-yl, 4-C1-C6 alkylpiperidin-1-yl or NR2R2; R2 are each independently a C1 to C6 alkyl; R3 is 2-napthyl or phenyl para-substituted by W; W is H, F, CF3, C1-C6 alkoxy or phenyl; and R4 is H or CH3, or a pharmaceutically acceptable salt or solvate thereof.
    Type: Application
    Filed: September 2, 2004
    Publication date: June 30, 2005
    Inventors: Jeffrey Dodge, Charles Lugar